MIR

Mirion Technologies Inc

Add to Watchlist

Advanced Chart

23.880

+0.75(3.243%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

24.770

Open

23.460

VWAP

24.07

Vol

6.47M

Mkt Cap

5.98B

Low

23.210

Amount

155.72M

EV/EBITDA(TTM)

34.16

Total Shares

231.46M

6.41B

EV/OCF(TTM)

50.88

P/S(TTM)

5.80

Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis, and monitoring solutions to the medical, nuclear, defense, and research end markets. The Company's segments include Nuclear & Safety and Medical. The Medical includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segment’s principal product offering is Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For Nuclear Power Plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q1

FY2025Q4

FY2025Q3

221.78M

+9.79%

0.130

+30%

275.99M

+8.53%

0.171

+0.39%

224.10M

+8.36%

0.099

+24.09%

Estimates Revision

The market is revising Upward the revenue expectations for Mirion Technologies, Inc. (MIR) for FY2025, with the revenue forecasts being adjusted by 1.64% over the past three months. During the same period, the stock price has changed by 18.10%.

Revenue Estimates for FY2025

Revise Upward

+1.64%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+1.08%

In Past 3 Month

Stock Price

Go Up

+18.10%

In Past 3 Month

7 Analyst Rating

1.72% Upside

Wall Street analysts forecast MIR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MIR is 24.29 USD with a low forecast of 22.00 USD and a high forecast of 28.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

6 Buy

1 Hold

0 Sell

Strong Buy

1.72% Upside

Current: 23.880

Low

22.00

Averages

24.29

High

28.00

1.72% Upside

Current: 23.880

Low

22.00

Averages

24.29

High

28.00

Baird

NULL -> Outperform

maintain

$23 -> $26

2025-09-29

Reason

Baird

Price Target

$23 -> $26

2025-09-29

maintain

NULL -> Outperform

Reason

Baird raised the firm's price target on Mirion to $26 from $23 and keeps an Outperform rating on the shares. The firm updated its estimates following its recent offering.

Northland

Outperform

maintain

$26 -> $29

2025-09-29

Reason

Northland

Price Target

$26 -> $29

2025-09-29

maintain

Outperform

Reason

Northland raised the firm's price target on Mirion to $29 from $26 and keeps an Outperform rating on the shares after the company announced the acquisition of Paragon Energy Solutions. The deal is accretive and it increases Mirion's revenue exposure to nuclear power to 45% from 37%, notes the analyst, who likes the agreement.

JPMorgan

Overweight

initiated

$28

2025-09-26

Reason

JPMorgan

Price Target

$28

2025-09-26

initiated

Overweight

Reason

JPMorgan initiated coverage of Mirion with an Overweight rating and $28 price target, implying 31% upside from current levels. Mirion is a global leader in radiation safety technologies, the analyst tells investors in a research note. The firm expects sustained earnings growth and shareholder value creation for the company due to its high single digit revenue growth, EBITDA margin expansion, and recurring revenue.

Baird

NULL

Outperform

maintain

$22 -> $23

2025-09-11

Reason

Baird

Price Target

$22 -> $23

2025-09-11

maintain

NULL

Outperform

Reason

Baird raised the firm's price target on Mirion to $23 from $22 and keeps an Outperform rating on the shares. The firm updated its model following meetings with management.

Northland

Outperform

initiated

$26

2025-08-25

Reason

Northland

Price Target

$26

2025-08-25

initiated

Outperform

Reason

Northland initiated coverage of Mirion with an Outperform rating and $26 price target. The radiation technology company has a presence in over 95% of the current global nuclear reactor fleet and is exposed to the attractive end markets of nuclear power and nuclear medicine, the analyst tells investors. The firm believes Mirion's mix of recurring revenue and growth upside will allow "investors to have their cake and eat it too," the analyst added.

B. Riley

Buy

maintain

$17 -> $22

2025-07-23

Reason

B. Riley

Price Target

$17 -> $22

2025-07-23

maintain

Buy

Reason

B. Riley raised the firm's price target on Mirion to $22 from $17 and keeps a Buy rating on the shares ahead of the Q2 report on July 31. Due to alleviated tariff concerns and elevated expectations, Mirion's Q2 report needs to meet consensus estimates to support the stock, the analyst tells investors in a research note. The firm believes the company is well positioned to benefit from the Trump administration's executive orders to accelerate the approval of nuclear reactors.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Mirion Technologies Inc (MIR.N) is 42.06, compared to its 5-year average forward P/E of 21.54. For a more detailed relative valuation and DCF analysis to assess Mirion Technologies Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Overvalued

5Y Average PE

21.54

Current PE

42.06

Overvalued PE

32.70

Undervalued PE

10.38

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

12.90

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

19.43

Undervalued EV/EBITDA

6.36

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

2.21

Current PS

0.00

Overvalued PS

3.46

Undervalued PS

0.97